Supplemental material
Human Vaccines & Immunotherapeutics
Volume 19, 2023 - Issue 1
HPV
Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017–2021)
Byung-Wook Euna Nowon Eulji University Hospital, Seoul, Republic of Korea
https://orcid.org/0000-0003-3147-9061View further author information
https://orcid.org/0000-0003-3147-9061View further author information, Enas Baharb GSK, Wavre, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0003-4827-8311View further author information
https://orcid.org/0000-0003-4827-8311View further author information, Stebin Xavierc GSK, Bengaluru, Indiahttps://orcid.org/0000-0002-7055-7790View further author information
https://orcid.org/0000-0002-7055-7790View further author information, & Dorota Borysb GSK, Wavre, Belgiumhttps://orcid.org/0000-0001-9704-8462View further author information
https://orcid.org/0000-0001-9704-8462View further author information